<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="37">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04581135</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00799</org_study_id>
    <nct_id>NCT04581135</nct_id>
  </id_info>
  <brief_title>Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19</brief_title>
  <official_title>Prospective Observational Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective Observational Swiss Cohort Study to Investigate Long-term Pulmonary and&#xD;
      Extrapulmonary Effects of COVID-19.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COVID-19 is a coronavirus induced viral pneumonia leading to Acute Respiratory Distress&#xD;
      Syndrome. Previous coronavirus infections (SARS and MERS) led to pulmonary fibrosis in up to&#xD;
      30%. Prospective evaluation of lung abnormalities and pulmonary fibrosis after COVID-19&#xD;
      infection is crucial as novel treatments against lung fibrosis of different etiologies are&#xD;
      available. No data on pulmonary longterm effects in COVID-19 survivors are currently&#xD;
      available. The nation-wide Swiss COVID-19 lung group establishes a meticulously characterized&#xD;
      prospective cohort study on pulmonary long-term sequela of patients living in Switzerland.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>36 Months</target_duration>
  <primary_outcome>
    <measure>Pulmonary follow-up sequelae in patients after COVID-19</measure>
    <time_frame>36 months</time_frame>
    <description>Number of patients with the long-term pulmonary complications by measuring lung function, exercise testing and radiological Imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of risk factors for adverse Outcome after COVID-19</measure>
    <time_frame>36 months</time_frame>
    <description>Number of patients with risk factors including comorbidities and other cofactors and correlate them to adverse outcome in patients after COVID-19</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the functional Pulmonary outcome of COVID-19 disease</measure>
    <time_frame>36 months</time_frame>
    <description>Compare pulmonary function measurements between mild and moderate to severe and critical COVID-19 disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the radiological Pulmonary outcome of COVID-19 disease</measure>
    <time_frame>36 months</time_frame>
    <description>Compare imaging measurements between mild and moderate to severe and critical COVID-19 disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life after COVID-19</measure>
    <time_frame>36 months</time_frame>
    <description>Compare Quality of Life questionnaires between mild and moderate to severe and critical COVID-19 disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical performance after COVID-19 using Clinical Frailty Scale</measure>
    <time_frame>36 months</time_frame>
    <description>To observe and compare the physical performance after COVID-19 via the Clinical Frailty Scale between mild and moderate to severe and critical COVID-19 disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical performance after COVID-19 using frailty assessment tests</measure>
    <time_frame>36 months</time_frame>
    <description>To observe and compare the physical performance after COVID-19 via frailty assessment tests between mild and moderate to severe and critical COVID-19 disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiota and COVID-19</measure>
    <time_frame>36 months</time_frame>
    <description>Number of patients with changes in microbiota in response to COVID-19 by microbiota analysis of sputa, bronchoalveolar lavage and swaps</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>COVID-19 Lung</arm_group_label>
    <description>COVID-19 survivors in Switzerland</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>COVID-19</intervention_name>
    <description>Research project in which biological material is sampled and health-related personal data are collected and used for further research. Coded data are used.</description>
    <arm_group_label>COVID-19 Lung</arm_group_label>
    <other_name>Sampling biological material</other_name>
    <other_name>Collection of health-related personal data</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Coded biological material&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients included are survivors of COVID-19.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed written informed consent.&#xD;
&#xD;
          -  All adult patients with COVID-19 over 18 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe mental or physical disability precluding informed consent or compliance with&#xD;
             the protocol for prospective data collection.&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuela Funke-Chambour, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Bern, Department of Pulmonary Medicine - Lead Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manuela Funke-Chambour, MD</last_name>
    <phone>+4131 632 21 11</phone>
    <email>Manuela.Funke-Chambour@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Claraspital AG - Department of Pulmonary Medicine</name>
      <address>
        <city>Basel</city>
        <zip>4002</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian R. Ott, PD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universtiy Hospital Bern (Inselspital), Department of Pulmonary Medicine - Lead Center</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuela Funke-Chambour, PD</last_name>
      <phone>+41316322111</phone>
      <phone_ext>+41316322111</phone_ext>
      <email>Manuela.Funke-Chambour@insel.ch</email>
    </contact>
    <contact_backup>
      <last_name>Kurt De Jaegere</last_name>
      <phone>+41316322111</phone>
      <email>kurt.dejaegere@insel.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University and Hospital of Fribourg</name>
      <address>
        <city>Fribourg</city>
        <zip>1708</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Mancinetti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Genève - Service de Pneumologie</name>
      <address>
        <city>Genève</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paola Gasche Soccal, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUV - Service de Pneumologie</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe von Garnier, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Moncucco</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Garzoni, PD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital du Valais - Service de Pneumologie</name>
      <address>
        <city>Sion</city>
        <zip>1950</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Olivier Bridevaux, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kantonspital St. Gallen - Klinik für Pneumologie und Schlafmedizin Lungenzentrum</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Brutsche, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Zürich - Klinik für Pneumologie</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Clarenbach, PD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 17, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Coronavirus infection</keyword>
  <keyword>Lung abnormalities</keyword>
  <keyword>Radiological abnormalities</keyword>
  <keyword>ARDS</keyword>
  <keyword>Quality of Life</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

